Honroth Eric
Honroth Eric, PRES, reported a transaction classified as grant at ANGIODYNAMICS INC involving 38265.000000 shares for an estimated $0.00. Reported holdings after the transaction were 101193.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Nov 02, 2026
- Filing date
- Nov 04, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ANGO price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001140361-26-041989 Common Stock
- Transaction date
- Nov 02, 2026 Filed Nov 04, 2026, 11:56 PM · 2d delay
- Shares
- 38,265 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 101,193 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-12 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - grant_or_award-22 points
transaction_code = A
Grant or award transactions are scheduled compensation, not discretionary.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President and CEO
- F1
The acquisition of 62,928 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company") represents 62,928 restricted stock units, each of which represents a contingent right to receiv…
- F2
The acquisition of 38,265 shares of Common Stock represents 38,265 restricted stock units granted to replace equity compensation the Reporting Person forfeited at his prior employer, each of which rep…
- F3
Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200…
0 other transactions
0 recent txs